title: [Primary arterial pulmonary hypertension and sildenafil: a case report from Dakar].
abstract: BACKGROUND
  We report our experience of using sildenafil in treatment on primary arterial pulmonary hypertension.
  
  
  METHODS
  This case concern a 38 years old senegalese woman. She was hospitalised for global cardiac failure with right signs predominance and grade IV dyspnea related to pulmonary hypertension.
  
  
  RESULTS
  No evident cause of the pulmonary hypertension had been found after explorations. Adding sildénafil to her symptomatic treatment provided fast favourable evolution quantified by clinical test and Doppler-ultrasound heart examination. However the patient died three month later by cerebral hemorrhage due to overdose of antivitamine K.
  
  
  CONCLUSIONS
  We suggest using sildenafil in the treatment of primary arterial pulmonary hypertension on the way going to cardio-pulmonary transplantation.
authors.affiliation: Service Brevié Hôpital Principal de Dakar.
authors.forename: M
authors.initials: M
authors.lastname: Bouldouyre
authors.forename: D
authors.initials: D
authors.lastname: Dia
authors.forename: Fall K
authors.initials: FK
authors.lastname: Ba
authors.forename: I B
authors.initials: IB
authors.lastname: Diop
authors.forename: J M
authors.initials: JM
authors.lastname: Debonne
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011687:Purines / Q000627:therapeutic use; D012675:Senegal; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate